Skip to main content

Prokupets Elena's Form 4 filing

C4 Therapeutics, Inc. (CCCC) · filed Sep 24, 2021

Accession no.
0001209191-21-057633
Filed
Sep 24, 2021
Trade date
Sep 22-24, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.65M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prokupets ElenaCIK 0001824823Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 22, 2021Common StockSSaleDisposed−3,544$50.10−$177,554.439,492Indirect
Sep 22, 2021Common StockSSaleDisposed−7,004$50.09−$350,830.36519,360Indirect
Sep 23, 2021Common StockSSaleDisposed−5,926$50.35−$298,374.133,566Indirect
Sep 23, 2021Common StockSSaleDisposed−446$51.09−$22,786.1433,120Indirect
Sep 23, 2021Common StockSSaleDisposed−11,801$50.35−$594,180.35507,559Indirect
Sep 23, 2021Common StockSSaleDisposed−1,007$51.08−$51,437.56506,552Indirect
Sep 24, 2021Common StockSSaleDisposed−900$50.11−$45,09932,220Indirect
Sep 24, 2021Common StockSSaleDisposed−2,115$50.10−$105,961.5504,437Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)